|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | November 3, 1999 | ||||||||
| Last Updated Date | September 19, 2009 | ||||||||
| Start Date ICMJE | January 1997 | ||||||||
| Estimated Primary Completion Date | November 2001 (final data collection date for primary outcome measure) | ||||||||
| Current Primary Outcome Measures ICMJE | |||||||||
| Original Primary Outcome Measures ICMJE |
To evaluate the feasibility of using G-CSF mobilized donor blood to transplant a predetermined dose of stem cells and T lymphocytes to recipients with hematologic malignacies. | ||||||||
| Change History | Complete list of historical versions of study NCT00001621 on ClinicalTrials.gov Archive Site | ||||||||
| Current Secondary Outcome Measures ICMJE | |||||||||
| Original Secondary Outcome Measures ICMJE | |||||||||
| Descriptive Information | |||||||||
| Brief Title ICMJE | Evaluation and Treatment of Patients With Lung Disease Not Participating in Research | ||||||||
| Official Title ICMJE | Evaluation and Treatment of Pulmonary Patients Not Participating in Research (Training Protocol) | ||||||||
| Brief Summary | This study was developed in order for the professional-staff at the Pulmonary-Critical Care Medical Branch (PCCMB) of the National Heart, Lung, and Blood Institute to maintain their skills and increase their understanding of lung diseases. The study will permit PCCMB staff members to evaluate and treat patients with lung disease who do not meet the criteria for other research studies. |
||||||||
| Detailed Description | The professional staff in theTranslational Medicine Branch (TMB) and Pulmonary and Vascular Medicine Branch (PVMB) needs to maintain their clinical skills to enhance their clinical knowledge. The purpose of this protocol is to permit TMB and PVMB staff to evaluate and treat patients with pulmonary disease who do not meet the criteria for existing research protocols. |
||||||||
| Study Phase | |||||||||
| Study Type ICMJE | Observational | ||||||||
| Study Design ICMJE | |||||||||
| Condition ICMJE | Lung Disease | ||||||||
| Intervention ICMJE | |||||||||
| Study Arms / Comparison Groups | |||||||||
| Publications * | |||||||||
|
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status ICMJE | Recruiting | ||||||||
| Enrollment ICMJE | 99999999 | ||||||||
| Completion Date | |||||||||
| Estimated Primary Completion Date | November 2001 (final data collection date for primary outcome measure) | ||||||||
| Eligibility Criteria ICMJE |
Patients 8 years old and older with signs or symptoms of pulmonary disease of medical interest to the professional staff of PCCMB will be eligible for participation in this protocol. Children under the age of 18 who need medically indicated procedures will not be assented unless the child's dissent will be honored. Only standard diagnostic procedures and conventional therapy will be performed. Patients will not be subjected to any research procedures. This protocol does not commit the NIH to medical or surgical treatment of protocol participants after discharge. Patients will be discharged to the referring physician. Consenting to pregnancy testing in minors of childbearing age: We will inform the minor during the assent process that for safety, we need to do a pregnancy test. She will also be told that if it is positive, we will counsel her and help her tell her parents. If the minor does not want to proceed she will be advised not to sign assent and her enrollment on this training protocol will end. EXCLUSION CRITERIA: Patients without symptoms of pulmonary disease will be excluded from this protocol. |
||||||||
| Gender | Both | ||||||||
| Ages | 8 Years and older | ||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts ICMJE |
|
||||||||
| Location Countries ICMJE | United States | ||||||||
| Administrative Information | |||||||||
| NCT ID ICMJE | NCT00001621 | ||||||||
| Responsible Party | |||||||||
| Study ID Numbers ICMJE | 970061, 97-H-0061 | ||||||||
| Study Sponsor ICMJE | National Heart, Lung, and Blood Institute (NHLBI) | ||||||||
| Collaborators ICMJE | |||||||||
| Investigators ICMJE | |||||||||
| Information Provided By | National Institutes of Health Clinical Center (CC) | ||||||||
| Verification Date | July 2009 | ||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||
